Mainz Biomed B.V.
Mainz Biomed B.V. (MYNZ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MYNZ · as of Jun 8, 2026
Key Statistics
Explore Mainz Biomed B.V. Data
mynz stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 33.3%
Competitors & Peers
mynz competitorsMYNZ
BNBX
BNGO
CHEK
FLGC
GBSStock Performance
Full HistoryAbout Mainz Biomed B.V.
Mainz Biomed B.V. a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a col…
what is mainz biomed b.v. · mynz stock overview · mainz biomed b.v. company profile · who is mainz biomed b.v. ceo · mynz NASDAQ · mainz biomed b.v. headquarters · mainz biomed b.v. business segments
About Stock Overview & Key Data
Mainz Biomed B.V. (MYNZ) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Nov 5, 2021. As of the latest trading session, MYNZ stock price is $3.59, with a market capitalization of $14.7M. The stock has returned +74.27% over the past 12 months and +220.54% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Mainz Biomed B.V. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Mainz Biomed B.V. reported revenue of $537080.00 and net income of -$16.2M. For detailed data — including Mainz Biomed B.V. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Mainz Biomed B.V. (MYNZ) stock price is $3.59. The stock is traded on NASDAQ under the ticker symbol MYNZ. The 52-week range is $0.55 – $5.34.